LianBio (LIANY) Financials

LIANY Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2023 618.0 million 36.8 million
Sept. 30, 2023 262.9 million 26.8 million
June 30, 2023 278.8 million 23.3 million
March 31, 2023 302.6 million 28.2 million

LIANY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 311.4 million ?
Sept. 30, 2023 -16.0 million 4.5 million
June 30, 2023 -19.2 million 4.5 million
March 31, 2023 -17.6 million 4.3 million

LIANY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2023 383.7 million
Sept. 30, 2023 -24.0 million
June 30, 2023 -21.4 million
March 31, 2023 -24.0 million

LIANY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 567.4 million - 511000
Sept. 30, 2023 252.2 million - 2.8 million
June 30, 2023 267.3 million - 3.3 million
March 31, 2023 286.5 million - 3.9 million

LIANY Shares Outstanding

No data available :(

LIANY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 146662 6.1 million 16.0 million -
Sept. 30, 2023 159431 9.0 million 17.3 million -
June 30, 2023 49617 9.4 million 15.1 million -464000
March 31, 2023 18962 10.8 million 15.1 million -

LIANY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 - 347371
Sept. 30, 2023 - 300018
June 30, 2023 - 296781
March 31, 2023 - 323366

LIANY

Price: $0.11

52 week price:
0.03
0.44

Dividend Yield: 268.75%

Earnings Per Share: -1.38 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 17.5 million

Links: